Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 7 of 7 items for :

  • "structural recurrence" x
Clear All
Eijun Nishihara Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Eijun Nishihara in
Google Scholar
PubMed Close
,
Yoshitaka Hobo ASKA Pharmamedical Co., Ltd. Fujisawa, Japan

Search for other papers by Yoshitaka Hobo in
Google Scholar
PubMed Close
,
Akira Miyauchi Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Akira Miyauchi in
Google Scholar
PubMed Close
,
Yasuhiro Ito Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed Close
,
Miyoko Higuchi Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Miyoko Higuchi in
Google Scholar
PubMed Close
,
Mitsuyoshi Hirokawa Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed Close
,
Mitsuru Ito Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Mitsuru Ito in
Google Scholar
PubMed Close
,
Shuji Fukata Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Shuji Fukata in
Google Scholar
PubMed Close
,
Mitsushige Nishikawa Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Mitsushige Nishikawa in
Google Scholar
PubMed Close
, and
Takashi Akamizu Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan

Search for other papers by Takashi Akamizu in
Google Scholar
PubMed Close

been used to evaluate structural recurrence in patients with thyroid cancer and positive TgAb in several clinical trials ( 6 , 9 , 10 ). However, no clear advantage has been proven for Tg-LC-MS/MS over immunoassays because of undetectable Tg values in

Article Type:
Research Article
Collections:
Thyroid function tests
DOI:
https://doi.org/10.1530/ETJ-21-0041
Volume/Issue:
Volume 11: Issue 1
Open access
Amanda La Greca Endocrinology Service, Department of Medicine, New York, N.Y., USA

Search for other papers by Amanda La Greca in
Google Scholar
PubMed Close
,
Bin Xu Department of Pathology, Memorial Sloan-Kettering Cancer Center and Weill-Cornell College of Medicine, New York, N.Y., USA

Search for other papers by Bin Xu in
Google Scholar
PubMed Close
,
Ronald Ghossein Department of Pathology, Memorial Sloan-Kettering Cancer Center and Weill-Cornell College of Medicine, New York, N.Y., USA

Search for other papers by Ronald Ghossein in
Google Scholar
PubMed Close
,
R. Michael Tuttle Endocrinology Service, Department of Medicine, New York, N.Y., USA

Search for other papers by R. Michael Tuttle in
Google Scholar
PubMed Close
, and
Mona M. Sabra Endocrinology Service, Department of Medicine, New York, N.Y., USA

Search for other papers by Mona M. Sabra in
Google Scholar
PubMed Close

]. In the absence of studies estimating the risk of structural recurrence in these patients, the treating physician often errs on the side of caution, electing to administer RAI ablation to patients presenting with multifocal macroscopic papillary

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000448752
Volume/Issue:
Volume 6: Issue 1
Free access
Saleha Babli Division of Endocrinology and Metabolism, Department of Medicine, Montreal General Hospital, McGill University, Montreal, Québec, Canada
Department of Endocrinology and Diabetes, Prince Sultan Military Medical City, Riyadh, Saudi Arabia

Search for other papers by Saleha Babli in
Google Scholar
PubMed Close
,
Richard J.  Payne Department of Otolaryngology, Royal Victoria Hospital, McGill University, Montreal, Québec, Canada

Search for other papers by Richard J.  Payne in
Google Scholar
PubMed Close
,
Elliot Mitmaker Department of Surgery, Montreal General Hospital, McGill University, Montreal, Québec, Canada

Search for other papers by Elliot Mitmaker in
Google Scholar
PubMed Close
, and
Juan Rivera Division of Endocrinology and Metabolism, Department of Medicine, Montreal General Hospital, McGill University, Montreal, Québec, Canada

Search for other papers by Juan Rivera in
Google Scholar
PubMed Close

positive TgAb. This patient was operated in 2007, and initial evaluation showed declining TgAb level as well as negative neck US and iodine whole-body scan; however, 3 years later, TgAb started to rise. Structural recurrence was confirmed by neck US (PTC

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000486367
Volume/Issue:
Volume 7: Issue 2
Free access
Yalin Iscan Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Yalin Iscan in
Google Scholar
PubMed Close
,
Ismail Cem Sormaz Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Ismail Cem Sormaz in
Google Scholar
PubMed Close
,
Fatih Tunca Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Fatih Tunca in
Google Scholar
PubMed Close
, and
Yasemin Giles Senyurek Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Search for other papers by Yasemin Giles Senyurek in
Google Scholar
PubMed Close

study by Hay et al. [ 18 ], 17% of PMC patients received postoperative RAI ablation treatment, and structural recurrence was reported during follow-up. However, in the study by Pelizzo et al. [ 7 ] 64.5% of PMC patients received postoperative radioactive

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000501613
Volume/Issue:
Volume 8: Issue 5
Free access
Ayanthi Wijewardene Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Ayanthi Wijewardene in
Google Scholar
PubMed Close
,
Matti Gild Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Matti Gild in
Google Scholar
PubMed Close
,
Carolina Nylén Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Carolina Nylén in
Google Scholar
PubMed Close
,
Geoffrey Schembri Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Geoffrey Schembri in
Google Scholar
PubMed Close
,
Paul Roach Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Paul Roach in
Google Scholar
PubMed Close
,
Jeremy Hoang Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Nuclear Medicine Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Jeremy Hoang in
Google Scholar
PubMed Close
,
Ahmad Aniss Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Ahmad Aniss in
Google Scholar
PubMed Close
,
Anthony Glover Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Anthony Glover in
Google Scholar
PubMed Close
,
Mark Sywak Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Mark Sywak in
Google Scholar
PubMed Close
,
Stan Sidhu Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia
Endocrine Surgery Department, Royal North Shore Hospital, Sydney, New South Wales, Australia

Search for other papers by Stan Sidhu in
Google Scholar
PubMed Close
,
Diana Learoyd Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Diana Learoyd in
Google Scholar
PubMed Close
,
Bruce Robinson Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Bruce Robinson in
Google Scholar
PubMed Close
,
Lyndal Tacon Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Lyndal Tacon in
Google Scholar
PubMed Close
, and
Roderick Clifton-Bligh Department of Endocrinology, Royal North Shore Hospital, Sydney, New South Wales, Australia
Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed Close

shifted over the past decade towards the use of lower RAI activities. The HiLo and ESTIMABL1 studies showed no difference in biochemical or structural recurrence following 1.1 GBq (29.7 mCi) or 3.7 GBq (100 mCi) for low-risk patients treated with ablative

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000516358
Volume/Issue:
Volume 10: Issue 5
Free access
Nicholas S. Andresen Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nicholas S. Andresen in
Google Scholar
PubMed Close
,
John M. Buatti Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Buatti in
Google Scholar
PubMed Close
,
Hamed H. Tewfik Iowa City Cancer Treatment Center, Iowa City, Iowa, USA

Search for other papers by Hamed H. Tewfik in
Google Scholar
PubMed Close
,
Nitin A. Pagedar Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Nitin A. Pagedar in
Google Scholar
PubMed Close
,
Carryn M. Anderson Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by Carryn M. Anderson in
Google Scholar
PubMed Close
, and
John M. Watkins Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, USA

Search for other papers by John M. Watkins in
Google Scholar
PubMed Close

39 Kruijff S, Aniss AM, Chen P, Sidhu SB, Delbridge LW, Robinson B, Clifton-Bligh RJ, Roach P, Gill AJ, Learoyd D, Sywak MS: Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000468927
Volume/Issue:
Volume 6: Issue 4
Free access
Jiahui Wu Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Jiahui Wu in
Google Scholar
PubMed Close
,
Xunyang Hu Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Xunyang Hu in
Google Scholar
PubMed Close
,
Paula Seal EFW Radiology, Calgary, Alberta, Canada
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Paula Seal in
Google Scholar
PubMed Close
,
Parthiv Amin Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Parthiv Amin in
Google Scholar
PubMed Close
,
Brendan Diederichs Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Mayfair Radiology, Calgary, Alberta, Canada

Search for other papers by Brendan Diederichs in
Google Scholar
PubMed Close
, and
Ralf Paschke Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

Search for other papers by Ralf Paschke in
Google Scholar
PubMed Close

risk (RR) thyroid cancer patients with a median FU of 10 years further demonstrated false-positive ultrasound abnormalities in 57% and structural recurrence in only 10% ( 4 ). Based on these findings, the authors suggested surveillance neck ultrasound

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-23-0110
Volume/Issue:
Volume 12: Issue 5
Open access